ScholarLens Back to search
2005•Journal of Internal Intensive MedicineRequires access

Observation of Effects of TEAA Regimen for Refractory and Relapsed Acute Leukemia

Xia Yunjin

Open publisher page 0 citations

Abstract

Objective: To explore the therapeutic protocol for refractory and relapsed acute leukemia(AL).Methods: 27 cases of refractory and relapsed AL were treated with TEAA(THP,VP16,AMSA,Ara-C) regimen,which consisted of THP10mg/d(d1~3),VP16 100mg/d(d1~4),AMSA75mg/d(d1~3),intravenous drip,Ara-C200mg/d(d1~7),intravenous drip.Results: 17 patients((59.3%)) achieved complete remission,5 patients((18.5%)) achieved partial remission,overall effective rate was(77.8%).Conclusions: TEAA regimen in treatment of refractory and relapsed AL is an effective means.

About this research paper

What this paper is about

Objective: To explore the therapeutic protocol for refractory and relapsed acute leukemia(AL).Methods: 27 cases of refractory and relapsed AL were treated with TEAA(THP,VP16,AMSA,Ara-C) regimen,which consisted of THP10mg/d(d1~3),VP16 100mg/d(d1~4),AMSA75mg/d(d1~3),intravenous drip,Ara-C200mg/d(d1~7),intravenous drip.Results: 17 patients((59.3%)) achieved complete remission,5 patients((18.5%)) achieved partial remission,overall effective rate was(77.8%).Conclusions: TEAA regimen in treatment of refractory and relapsed AL is an effective means.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To explore the therapeutic protocol for refractory and relapsed acute leukemia(AL).Methods: 27 cases of refractory and relapsed AL were treated with TEAA(THP,VP16,AMSA,Ara-C) regimen,which consisted of THP10mg/d(d1~3),VP16 100mg/d(d1~4),AMSA75mg/d(d1~3),intravenous drip,Ara-C200mg/d(d1~7),intravenous drip.Results: 17 patients((59.3%)) achieved complete remission,5 patients((18.5%)) achieved partial remission,overall effective rate was(77.8%).Conclusions: TEAA regimen in treatment of refractory and relapsed AL is an effective means.

Key concepts: Refractory (planetary science), Medicine, Regimen, Acute leukemia, Internal medicine, Complete remission, Gastroenterology, Leukemia

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Observation of Effects of TEAA Regimen for Refractory and Relapsed Acute Leukemia — Research Paper | ScholarLens